Trial Profile
Open-label, single arm trial to investigate the efficacy of TKM-130803 with a concurrent observational study of Ebolavirus Disease in an outbreak setting in West Africa
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 07 May 2019
Price :
$35
*
At a glance
- Drugs TKM Ebola (Primary)
- Indications Ebola virus infections
- Focus Therapeutic Use
- Acronyms RAPIDE-TKM
- 29 Apr 2019 Planned initiation date changed to 16 Feb 2015.
- 16 Sep 2016 New trial record